Nuvalent (NUVL) Shares Issued (2021 - 2026)
Nuvalent's (NUVL) quarterly Shares Issued came in at $7.8 million in Q1 2026, up 64.67% YoY from $4.8 million in Q1 2025, and up 1.71% on a QoQ basis from $7.7 million in Q4 2025.
Nuvalent (NUVL) Shares Issued (2021 - 2026) Analysis & Trends
Nuvalent (NUVL) has 6 years of Shares Issued data on file, last reported at $7.8 million in Q1 2026.
- Quarterly Shares Issued rose 64.67% year-over-year to $7.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.8 million (up 64.67% YoY) and the FY2025 annual result came in at $7.7 million, down 3.29% from the prior year.
- Shares Issued climbed to $7.8 million in Q1 2026, from $7.7 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $8.7 million in Q2 2025 to a low of $4.1 million in Q2 2024.
- A 5-year average of $6.8 million and a median of $6.5 million in 2022 frame the typical range for Shares Issued.
- The widest YoY moves for Shares Issued: up 111.95% in 2025, down 45.23% in 2025.
- Tracing NUVL's Shares Issued over 5 years: stood at $6.5 million in 2022, then rose by 24.5% to $8.0 million in 2023, then retreated by 0.68% to $8.0 million in 2024, then dropped by 3.29% to $7.7 million in 2025, then gained by 1.71% to $7.8 million in 2026.
- The last three Shares Issued figures came in at $7.8 million (Q1 2026), $7.7 million (Q4 2025), and $8.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Nuvalent | 9.10 Bn | 9.10 Bn | - | 7.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.85 Mn |
| Mar 31, 2026 | 7.85 Mn |
| Dec 31, 2025 | 7.72 Mn |
| Dec 31, 2025 | 7.72 Mn |
| Sep 30, 2025 | 8.57 Mn |
| Sep 30, 2025 | 8.57 Mn |
| Jun 30, 2025 | 8.72 Mn |
| Jun 30, 2025 | 8.72 Mn |
| Mar 31, 2025 | 4.77 Mn |
| Mar 31, 2025 | 4.77 Mn |
| Dec 31, 2024 | 7.98 Mn |
| Dec 31, 2024 | 7.98 Mn |
| Sep 30, 2024 | 4.25 Mn |
| Sep 30, 2024 | 4.25 Mn |
| Jun 30, 2024 | 4.11 Mn |
| Jun 30, 2024 | 4.11 Mn |
| Mar 31, 2024 | 8.70 Mn |
| Mar 31, 2024 | 8.70 Mn |
| Dec 31, 2023 | 8.03 Mn |
| Dec 31, 2023 | 8.03 Mn |